<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#Cover" roleURI="http://oncotelic.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#BalanceSheets" roleURI="http://oncotelic.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#BalanceSheetsParenthetical" roleURI="http://oncotelic.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#StatementsOfOperations" roleURI="http://oncotelic.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#CondensedConsolidatedStatementOfStockholdersEquity" roleURI="http://oncotelic.com/role/CondensedConsolidatedStatementOfStockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#StatementsOfCashFlows" roleURI="http://oncotelic.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#DescriptionOfBusinessAndBasisOfPresentation" roleURI="http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentation" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfSignificantAccountingPolicies" roleURI="http://oncotelic.com/role/SummaryOfSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#AcquisitionsGoodwillAndIntangibleAssets" roleURI="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssets" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#AccountsPayableAndAccruedLiabilities" roleURI="http://oncotelic.com/role/AccountsPayableAndAccruedLiabilities" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ConvertibleDebenturesNotesAndOtherDebt" roleURI="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebt" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#JointVentureWithGmpBioAndAffiliatesEquityMethodInvestment" roleURI="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestment" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-2Ppm-2AndJhDarbieFunding" roleURI="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFunding" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-3Ppm-3AndJhDarbieFunding" roleURI="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFunding" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#LunaiBioworksTransactions" roleURI="http://oncotelic.com/role/LunaiBioworksTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#RelatedPartyTransactions" roleURI="http://oncotelic.com/role/RelatedPartyTransactions" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#EquityPurchaseAgreementAndRegistrationRightsAgreementMastHill" roleURI="http://oncotelic.com/role/EquityPurchaseAgreementAndRegistrationRightsAgreementMastHill" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#StockholdersEquity" roleURI="http://oncotelic.com/role/StockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PreferredStock" roleURI="http://oncotelic.com/role/PreferredStock" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#Stock-basedCompensation" roleURI="http://oncotelic.com/role/Stock-basedCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#CommitmentsAndContingencies" roleURI="http://oncotelic.com/role/CommitmentsAndContingencies" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SubsequentEvents" roleURI="http://oncotelic.com/role/SubsequentEvents" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" roleURI="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfSignificantAccountingPoliciesTables" roleURI="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#AcquisitionsGoodwillAndIntangibleAssetsTables" roleURI="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#AccountsPayableAndAccruedLiabilitiesTables" roleURI="http://oncotelic.com/role/AccountsPayableAndAccruedLiabilitiesTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ConvertibleDebenturesNotesAndOtherDebtTables" roleURI="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentTables" roleURI="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-2Ppm-2AndJhDarbieFundingTables" roleURI="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-3Ppm-3AndJhDarbieFundingTables" roleURI="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFundingTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PreferredStockTables" roleURI="http://oncotelic.com/role/PreferredStockTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#Stock-basedCompensationTables" roleURI="http://oncotelic.com/role/Stock-basedCompensationTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SubsequentEventsTables" roleURI="http://oncotelic.com/role/SubsequentEventsTables" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" roleURI="http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" roleURI="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfUnrealizedGainsAndLossesDetails" roleURI="http://oncotelic.com/role/ScheduleOfUnrealizedGainsAndLossesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfFairValueOfInvestmentHierarchyDetails" roleURI="http://oncotelic.com/role/ScheduleOfFairValueOfInvestmentHierarchyDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfQuantitativeInformationAboutSignificantUnobservableInputsDetails" roleURI="http://oncotelic.com/role/ScheduleOfQuantitativeInformationAboutSignificantUnobservableInputsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfChangesInFairValueOfDerivativeLiabilitiesDetails" roleURI="http://oncotelic.com/role/SummaryOfChangesInFairValueOfDerivativeLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SummaryOfEstimateFairValueOfDerivativeLiabilitiesDetails" roleURI="http://oncotelic.com/role/SummaryOfEstimateFairValueOfDerivativeLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfGoodwillDetails" roleURI="http://oncotelic.com/role/ScheduleOfGoodwillDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#AcquisitionsGoodwillAndIntangibleAssetsDetailsNarrative" roleURI="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfAccountsPayableAndAccruedExpensesDetails" roleURI="http://oncotelic.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfConvertibleDebenturesAndNotesNetOfDiscountDetails" roleURI="http://oncotelic.com/role/ScheduleOfConvertibleDebenturesAndNotesNetOfDiscountDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfConvertibleNotesNetOfDiscountDetails" roleURI="http://oncotelic.com/role/ScheduleOfConvertibleNotesNetOfDiscountDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfNetOfDebtDiscountDetails" roleURI="http://oncotelic.com/role/ScheduleOfNetOfDebtDiscountDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfShort-termLoansDetails" roleURI="http://oncotelic.com/role/ScheduleOfShort-termLoansDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ConvertibleDebenturesNotesAndOtherDebtDetailsNarrative" roleURI="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfChangeInFairValueOfOurInvestmentDetails" roleURI="http://oncotelic.com/role/ScheduleOfChangeInFairValueOfOurInvestmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentDetailsNarrative" roleURI="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-2Ppm-2AndJhDarbieFundingDetailsNarrative" roleURI="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfFundsReceivedUnderSubscriptionAgreementDetails" roleURI="http://oncotelic.com/role/ScheduleOfFundsReceivedUnderSubscriptionAgreementDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfFairValueWarrantsDetails" roleURI="http://oncotelic.com/role/ScheduleOfFairValueWarrantsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PrivatePlacement-3Ppm-3AndJhDarbieFundingDetailsNarrative" roleURI="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFundingDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfDebtRecordedUnderSubscriptionAgreementDetails" roleURI="http://oncotelic.com/role/ScheduleOfDebtRecordedUnderSubscriptionAgreementDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#LunaiBioworksTransactionsDetailsNarrative" roleURI="http://oncotelic.com/role/LunaiBioworksTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#RelatedPartyTransactionsDetailsNarrative" roleURI="http://oncotelic.com/role/RelatedPartyTransactionsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#EquityPurchaseAgreementAndRegistrationRightsAgreementMastHillDetailsNarrative" roleURI="http://oncotelic.com/role/EquityPurchaseAgreementAndRegistrationRightsAgreementMastHillDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#StockholdersEquityDetailsNarrative" roleURI="http://oncotelic.com/role/StockholdersEquityDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfPreferredStockDetails" roleURI="http://oncotelic.com/role/ScheduleOfPreferredStockDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#PreferredStockDetailsNarrative" roleURI="http://oncotelic.com/role/PreferredStockDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfCompensationBasedStockOptionActivityDetails" roleURI="http://oncotelic.com/role/ScheduleOfCompensationBasedStockOptionActivityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfOptionsToPurchaseSharesOfCommonStockOutstandingAndExercisableDetails" roleURI="http://oncotelic.com/role/ScheduleOfOptionsToPurchaseSharesOfCommonStockOutstandingAndExercisableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfWarrantsActivityDetails" roleURI="http://oncotelic.com/role/ScheduleOfWarrantsActivityDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfWarrantsOutstandingAndExercisableDetails" roleURI="http://oncotelic.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#Stock-basedCompensationDetailsNarrative" roleURI="http://oncotelic.com/role/Stock-basedCompensationDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#CommitmentsAndContingenciesDetailsNarrative" roleURI="http://oncotelic.com/role/CommitmentsAndContingenciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#SubsequentEventsDetailsNarrative" roleURI="http://oncotelic.com/role/SubsequentEventsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="otlc-20260630.xsd#ScheduleOfRsuAwardsDetails" roleURI="http://oncotelic.com/role/ScheduleOfRsuAwardsDetails" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RestrictedCash" xlink:label="loc_us-gaapRestrictedCash" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFVNINoncurrent" xlink:label="loc_us-gaapEquitySecuritiesFVNINoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapEquitySecuritiesFVNINoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentOwnedAtFairValue" xlink:label="loc_us-gaapInvestmentOwnedAtFairValue" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInvestmentOwnedAtFairValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleDebtCurrent" xlink:label="loc_us-gaapConvertibleDebtCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleDebtNoncurrent" xlink:label="loc_us-gaapConvertibleDebtNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleDebtNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Condensed Consolidated Statements of Operations (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="otlc-20260630.xsd#OTLC_GainOnDerecognitionOfNonFinancialAsset" xlink:label="loc_OTLCGainOnDerecognitionOfNonFinancialAsset" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_OTLCGainOnDerecognitionOfNonFinancialAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFvNiGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiGainLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapEquitySecuritiesFvNiGainLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/CondensedConsolidatedStatementOfStockholdersEquity" xlink:title="00000005 - Statement -  Condensed Consolidated Statement of Stockholders&apos; Equity (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="otlc-20260630.xsd#OTLC_GainOnDerecognitionOfNonFinancialAsset" xlink:label="loc_OTLCGainOnDerecognitionOfNonFinancialAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_OTLCGainOnDerecognitionOfNonFinancialAsset" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EquitySecuritiesFvNiGainLoss" xlink:label="loc_us-gaapEquitySecuritiesFvNiGainLoss" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapEquitySecuritiesFvNiGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromConvertibleDebt" xlink:label="loc_us-gaapProceedsFromConvertibleDebt" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromConvertibleDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="999007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="999008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssets" xlink:title="999009 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="999010 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebt" xlink:title="999011 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestment" xlink:title="999012 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFunding" xlink:title="999013 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFunding" xlink:title="999014 - Disclosure - PRIVATE PLACEMENT -3 (&#8220;PPM-3&#8221;) AND JH DARBIE FUNDING" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/LunaiBioworksTransactions" xlink:title="999015 - Disclosure - LUNAI BIOWORKS TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/RelatedPartyTransactions" xlink:title="999016 - Disclosure - RELATED PARTY TRANSACTIONS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/EquityPurchaseAgreementAndRegistrationRightsAgreementMastHill" xlink:title="999017 - Disclosure - EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (MAST HILL)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/StockholdersEquity" xlink:title="999018 - Disclosure - STOCKHOLDERS&#8217; EQUITY" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PreferredStock" xlink:title="999019 - Disclosure - PREFERRED STOCK" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/Stock-basedCompensation" xlink:title="999020 - Disclosure - STOCK-BASED COMPENSATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/CommitmentsAndContingencies" xlink:title="999021 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SubsequentEvents" xlink:title="999022 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="999023 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="999024 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsTables" xlink:title="999025 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="999026 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtTables" xlink:title="999027 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentTables" xlink:title="999028 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingTables" xlink:title="999029 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFundingTables" xlink:title="999030 - Disclosure - PRIVATE PLACEMENT -3 (&#8220;PPM-3&#8221;) AND JH DARBIE FUNDING (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PreferredStockTables" xlink:title="999031 - Disclosure - PREFERRED STOCK (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/Stock-basedCompensationTables" xlink:title="999032 - Disclosure - STOCK-BASED COMPENSATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SubsequentEventsTables" xlink:title="999033 - Disclosure - SUBSEQUENT EVENTS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="999034 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="999035 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfUnrealizedGainsAndLossesDetails" xlink:title="999036 - Disclosure - SCHEDULE OF UNREALIZED GAINS AND LOSSES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfFairValueOfInvestmentHierarchyDetails" xlink:title="999037 - Disclosure - SCHEDULE OF FAIR VALUE OF INVESTMENT HIERARCHY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfQuantitativeInformationAboutSignificantUnobservableInputsDetails" xlink:title="999038 - Disclosure - SCHEDULE OF QUANTITATIVE INFORMATION ABOUT SIGNIFICANT UNOBSERVABLE INPUTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfChangesInFairValueOfDerivativeLiabilitiesDetails" xlink:title="999039 - Disclosure - SUMMARY OF CHANGES IN FAIR VALUE OF DERIVATIVE LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SummaryOfEstimateFairValueOfDerivativeLiabilitiesDetails" xlink:title="999040 - Disclosure - SUMMARY OF ESTIMATE FAIR VALUE OF DERIVATIVE LIABILITIES (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfGoodwillDetails" xlink:title="999041 - Disclosure - SCHEDULE OF GOODWILL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/AcquisitionsGoodwillAndIntangibleAssetsDetailsNarrative" xlink:title="999042 - Disclosure - ACQUISITIONS, GOODWILL AND INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:title="999043 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfConvertibleDebenturesAndNotesNetOfDiscountDetails" xlink:title="999044 - Disclosure - SCHEDULE OF CONVERTIBLE DEBENTURES AND NOTES, NET OF DISCOUNT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfConvertibleNotesNetOfDiscountDetails" xlink:title="999045 - Disclosure - SCHEDULE OF CONVERTIBLE NOTES, NET OF DISCOUNT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfNetOfDebtDiscountDetails" xlink:title="999046 - Disclosure - SCHEDULE OF NET OF DEBT DISCOUNT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfShort-termLoansDetails" xlink:title="999047 - Disclosure - SCHEDULE OF SHORT-TERM LOANS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ConvertibleDebenturesNotesAndOtherDebtDetailsNarrative" xlink:title="999048 - Disclosure - CONVERTIBLE DEBENTURES, NOTES AND OTHER DEBT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfChangeInFairValueOfOurInvestmentDetails" xlink:title="999049 - Disclosure - SCHEDULE OF CHANGE IN FAIR VALUE OF OUR INVESTMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/JointVentureWithGmpBioAndAffiliatesEquityMethodInvestmentDetailsNarrative" xlink:title="999050 - Disclosure - JOINT VENTURE WITH GMP BIO AND AFFILIATES, EQUITY METHOD INVESTMENT (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-2Ppm-2AndJhDarbieFundingDetailsNarrative" xlink:title="999051 - Disclosure - PRIVATE PLACEMENT -2 (PPM-2) AND JH DARBIE FUNDING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfFundsReceivedUnderSubscriptionAgreementDetails" xlink:title="999052 - Disclosure - SCHEDULE OF FUNDS RECEIVED UNDER THE SUBSCRIPTION AGREEMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfFairValueWarrantsDetails" xlink:title="999053 - Disclosure - SCHEDULE OF FAIR VALUE WARRANTS (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PrivatePlacement-3Ppm-3AndJhDarbieFundingDetailsNarrative" xlink:title="999054 - Disclosure - PRIVATE PLACEMENT -3 (&#8220;PPM-3&#8221;) AND JH DARBIE FUNDING (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfDebtRecordedUnderSubscriptionAgreementDetails" xlink:title="999055 - Disclosure - SCHEDULE OF DEBT RECORDED UNDER THE SUBSCRIPTION AGREEMENT (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/LunaiBioworksTransactionsDetailsNarrative" xlink:title="999056 - Disclosure - LUNAI BIOWORKS TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="999057 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/EquityPurchaseAgreementAndRegistrationRightsAgreementMastHillDetailsNarrative" xlink:title="999058 - Disclosure - EQUITY PURCHASE AGREEMENT AND REGISTRATION RIGHTS AGREEMENT (MAST HILL) (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/StockholdersEquityDetailsNarrative" xlink:title="999059 - Disclosure - STOCKHOLDERS&#8217; EQUITY (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfPreferredStockDetails" xlink:title="999060 - Disclosure - SCHEDULE OF PREFERRED STOCK (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/PreferredStockDetailsNarrative" xlink:title="999061 - Disclosure - PREFERRED STOCK (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfCompensationBasedStockOptionActivityDetails" xlink:title="999062 - Disclosure - SCHEDULE OF COMPENSATION BASED STOCK OPTION ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfOptionsToPurchaseSharesOfCommonStockOutstandingAndExercisableDetails" xlink:title="999063 - Disclosure - SCHEDULE OF OPTIONS TO PURCHASE SHARES OF COMMON STOCK OUTSTANDING AND EXERCISABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfWarrantsActivityDetails" xlink:title="999064 - Disclosure - SCHEDULE OF WARRANTS ACTIVITY (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfWarrantsOutstandingAndExercisableDetails" xlink:title="999065 - Disclosure - SCHEDULE OF WARRANTS OUTSTANDING AND EXERCISABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/Stock-basedCompensationDetailsNarrative" xlink:title="999066 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="999067 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/SubsequentEventsDetailsNarrative" xlink:title="999068 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://oncotelic.com/role/ScheduleOfRsuAwardsDetails" xlink:title="999069 - Disclosure - SCHEDULE OF RSU AWARDS (Details)" />
</link:linkbase>
